Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SwissLens is a Swiss ophthalmic medical device company focused on the custom design and manufacture of specialty contact lenses for eye care professionals, hospitals, and distributors. The company offers made-to-order soft, rigid gas permeable, orthokeratology, scleral, keratoconus, prosthetic, colored, and myopia-management lenses, along with lens-care products and related accessories. SwissLens emphasizes personalized lens geometry, broad parameter ranges, and proprietary nano-precision manufacturing technology developed in collaboration with EPFL and other Swiss technology partners. Its products address both refractive correction and medical eye-care needs, including progressive myopia, keratoconus, irregular corneas, and presbyopia. The business appears to be fully commercial-stage rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SwissLens.